No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study

Autor: Prosperini, L, Annovazzi, P, Boffa, L, Buscarinu, Mc, Gallo, A, Matta, M, Moiola, L, Musu, L, Perini, P, Avolio, C, Barcella, V, Bianco, A, Farina, D, Ferraro, E, Pontecorvo, S, Granella, F, Grimaldi, Lme, Laroni, A, Lus, G, Patti, F, Pucci, E, Pasca, M, Sarchielli, P, Ghezzi, A, Zaffaroni, M, Baroncini, D, Buttari, F, Centonze, D, Fornasiero, A, Salvetti, M, Docimo, R, Signoriello, E, Tedeschi, G, Bertolotto, A, Capobianco, M, Comi, G, Cocco, E, Gallo, P, Puthenparampil, M, Grasso, R, Di Francescantonio, V, Rottoli, Mr, Mirabella, M, Lugaresi, A, De Luca, G, Di Ioia, M, Di Tommaso, V, Mancinelli, L, Di Battista, G, Francia, A, Ruggieri, S, Pozzilli, C, Curti, E, Tsantes, E, Palmeri, B, Lapucci, C, Mancardi, Gl, Uccelli, A, Chisari, C, D'Amico, E, Cartechini, E, Repice, Am, Magnani, E, Massaccesi, L, Calabresi, P, Di Filippo, M, Di Gregorio, M, Italian Alemtuzumab Study, Group.

Publikováno v: Journal of neurology. 265(12)

In this retrospective, multicenter, real-world study we collected clinical and magnetic resonance imaging (MRI) data of all patients (n = 40) with relapsing-remitting multiple sclerosis (RRMS) treated with alemtuzumab according to a "free-of-charge"

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc5d247585195cd879af5006a1512cd8
https://pubmed.ncbi.nlm.nih.gov/30259178

A real-world study of alemtuzumab in a cohort of Italian patients.

Autor: Russo CV; NSRO Department, University of Naples Federico II, Napoli, Italy., Saccà F; NSRO Department, University of Naples Federico II, Napoli, Italy., Frau J; Centro Sclerosi Multipla, ASSL Cagliari (ATS Sardegna); Dipartimento di Scienze Mediche e Sanità Pubblica, University of Cagliari, Cagliari, Italy., Annovazzi P; Multiple Sclerosis Center, ASST della Valle Olona, Hospital of Gallarate, Gallarate, Italy., Signoriello E; University of Campania Luigi Vanvitelli, Napoli, Italy., Bonavita S; University of Campania Luigi Vanvitelli, Napoli, Italy., Grasso R; University of Foggia, Foggia, Italy., Clerico M; Dipartimento di Scienze Cliniche e Biologiche, University of Torino, Torino, Italy., Cordioli C; Multiple Sclerosis Center, ASST Spedali Civili di Brescia, Montichiari Hospital, Montichiari, Italy., Laroni A; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health and Center of Excellence for Biomedical Research (CEBR) and IRCCS San Martino-IST, University of Genova, Genova, Italy., Capobianco M; SC Neurologia e Centro di Riferimento Regionale SM - AOU S. Luigi, Orbassano, Torino, Italy., Torri Clerici V; Neuro-Immunology and Neuromuscolar Diseases Unit, IRCCS Foundation Carlo Besta Neurological Institute, Milano, Italy., Sartori A; Clinical Unit of Neurology, Department of Medicine, Surgery and Health Sciences, ASUGI, University of Trieste, Trieste, Italy., Cavalla P; MS Center, City of Health & Science University Hospital, Torino, Italy., Maniscalco GT; Multiple Sclerosis Center 'A. Cardarelli' Hospital, Naples, Italy., La Gioia S; Centro Sclerosi Multipla, ASST Papa Giovanni XXIII, Bergamo, Italy., Caleri F; Neurology Department, F. Tappeiner Hospital Meran (BZ) of Neurology, Franz Tappeiner Hospital, Merano, Italy., Giugno A; Institute of Neurology, Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy., Iodice R; NSRO Department, University of Naples Federico II, Napoli, Italy., Carotenuto A; NSRO Department, University of Naples Federico II, Napoli, Italy., Cocco E; Centro Sclerosi Multipla, ASSL Cagliari (ATS Sardegna); Dipartimento di Scienze Mediche e Sanità Pubblica, University of Cagliari, Cagliari, Italy., Fenu G; Centro Sclerosi Multipla, ASSL Cagliari (ATS Sardegna); Dipartimento di Scienze Mediche e Sanità Pubblica, University of Cagliari, Cagliari, Italy., Zaffaroni M; Multiple Sclerosis Center, ASST della Valle Olona, Hospital of Gallarate, Gallarate, Italy., Baroncini D; Multiple Sclerosis Center, ASST della Valle Olona, Hospital of Gallarate, Gallarate, Italy., Lus G; University of Campania Luigi Vanvitelli, Napoli, Italy., Gallo A; University of Campania 'Luigi Vanvitelli', Napoli, Italy., De Mercanti SF; Dipartimento di Scienze Cliniche e Biologiche, University of Torino, Torino, Italy., Lapucci C; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health and Center of Excellence for Biomedical Research (CEBR) and IRCCS San Martino-IST, University of Genova, Genova, Italy., Di Francescantonio V; University of Foggia, Foggia, Italy., Brambilla L; Neuro-Immunology and Neuromuscolar Diseases Unit, IRCCS Foundation Carlo Besta Neurological Institute, Milano, Italy., Sormani MP; Department of Health Sciences (DISSAL), Section of Biostatistics, University of Genova, Genova, Italy., Signori A; Department of Health Sciences (DISSAL), Section of Biostatistics, University of Genova, Genova, Italy.

Publikováno v: European journal of neurology [Eur J Neurol] 2022 Jan; Vol. 29 (1), pp. 257-266. Date of Electronic Publication: 2021 Oct 05.

Dysregulation of miR-223, miR-146a, and miR-193a Expression Profile in Acute and Chronic Phases of Experimental Autoimmune Encephalomyelitis in C57BL/6 Mice.

Autor: Gharibi, Saba^1,2 (AUTHOR), Moghimi, Bahram² (AUTHOR), Mahmoudi, Mohammad Bagher³ (AUTHOR), Shahvazian, Ensieh³ (AUTHOR), Yazd, Ehsan Farashahi² (AUTHOR), Yadegari, Maryam⁴ (AUTHOR), Tahoori, Mohammad Taher⁵ (AUTHOR), Yazdanpanah, Esmaeil⁶ (AUTHOR), Haghmorad, Dariush⁶ (AUTHOR) dhaghmorad@gmail.com, Oksenych, Valentyn⁷ (AUTHOR) dhaghmorad@gmail.com

Publikováno v: Cells (2073-4409). Sep2024, Vol. 13 Issue 17, p1499. 14p.

Extracellular Vesicles: The Next Generation of Biomarkers and Treatment for Central Nervous System Diseases.

Autor: Zanirati, Gabriele¹ (AUTHOR) gabriele.zanirati@pucrs.br, dos Santos, Paula Gabrielli¹ (AUTHOR) fernanda.bruzzo@edu.pucrs.br, Alcará, Allan Marinho¹ (AUTHOR) isadora.ghilardi@edu.pucrs.br, Bruzzo, Fernanda¹ (AUTHOR) vinicius.wietholter@edu.pucrs.br, Ghilardi, Isadora Machado¹ (AUTHOR) fxavier@pucrs.br, Wietholter, Vinicius¹ (AUTHOR) joao.goncalves@edu.pucrs.br, Xavier, Fernando Antônio Costa¹ (AUTHOR) daniel.marinowic@pucrs.br, Gonçalves, João Ismael Budelon¹ (AUTHOR) jcc@pucrs.br, Marinowic, Daniel¹ (AUTHOR), Shetty, Ashok K.² (AUTHOR) ash.shetty@tamu.edu, da Costa, Jaderson Costa¹ (AUTHOR)

Publikováno v: International Journal of Molecular Sciences. Jul2024, Vol. 25 Issue 13, p7371. 36p.

Effect of fingolimod action on the release of monocyte-derived microvesicles in multiple sclerosis patients.

Autor: Amoruso A; Department of Medical and Surgical Sciences, University Of Foggia, Foggia, Italy. Electronic address: antonella.amoruso@unifg.it., Blonda M; Department of Medical and Surgical Sciences, University Of Foggia, Foggia, Italy., D'Arrigo G; Department of Neuroscience, Scuola Internazionale Superiore di Studi Avanzati (SISSA), Trieste, Italy., Grasso R; Department of Medical and Surgical Sciences, University Of Foggia, Foggia, Italy., Di Francescantonio V; Department of Medical and Surgical Sciences, University Of Foggia, Foggia, Italy., Verderio C; CNR Institute of Neuroscience, Milan, Italy., Avolio C; Department of Medical and Surgical Sciences, University Of Foggia, Foggia, Italy.

Publikováno v: Journal of neuroimmunology [J Neuroimmunol] 2018 Oct 15; Vol. 323, pp. 43-48. Date of Electronic Publication: 2018 Jul 17.